Section

Sun Pharma recalls 55,000 bottles of generic drug from US market due to manufacturing norms violation

By Economic Times - 4 months ago
Sun Pharma is recalling 55,000 bottles of Febuxostat Tablets, in 40 mg and 80 mg strengths, from the American market due to manufacturing practice deviations caused by microbial contamination at their Dadra-based plant.

Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.